glp-1 news updates november 2025 Pharmacy Pricing Update (Dec 2025) ISPOR 2025: Exploring reasons for

What to Expect on Your Journey with Semaglutide Beginning semaglutide treatment usually involves a gradual dosage increase as you adjust to its effects

For consumers unwilling or unable to pay for GLP-1 medications like Ozempic, Wegovy and Zepbound, the offers from compounding pharmacies rather than mainstream manufacturers of the drugs are appealing

Additionally, aligning manufacturing strategy with long-term adherence patterns and areas that indicate future expansion, such as sleep apnea, addiction, and oncology, can help manufacturers stay ahead in a fast-paced, rapidly evolving landscape

Carrier EJ, Auchampach JA, Hillard CJ

Regarding other GLP-1RAs, such as liraglutide and albiglutide, no dose adjustment is necessary in patients with renal impairment, as these drugs are not renally excreted